Immunophenotype of blood lymphocytes in neuroblastoma-associated opsoclonus-myoclonus

Journal of Pediatric Hematology/Oncology

Volumn 26, Issue 11, 2004, Pages 718-723

  Pranzatelli, Michael R ^a,e   Travelstead, Anna L ^a   Tate, Elizabeth D ^a   Allison, Tyler J ^a   Lee, Nadine D ^b   Fisher, Joan ^c   Jasty, Rama ^d  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INDIANA UNIVERSITY   (United States)

^c CARILION CLINIC   (United States)

^d MEDICAL COLLEGE OF OHIO   (United States)

^e SIU SOM   (United States)

Author keywords

ACTH; IVIG; Kinsbourne syndrome; Myoclonus; Neuroblastoma; Paraneoplastic syndrome

Indexed keywords

ANTINEOPLASTIC AGENT; CD19 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD8 ANTIGEN; HLA DR ANTIGEN;

AGE DISTRIBUTION; ARTICLE; B LYMPHOCYTE; CANCER CHEMOTHERAPY; CELL SIZE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; FEMALE; FLOW CYTOMETRY; GENDER; HUMAN; IMMUNOPHENOTYPING; MALE; MYOCLONUS; NATURAL KILLER CELL; NEUROBLASTOMA; OPSOCLONUS; OPSOCLONUS MYOCLONUS; PARANEOPLASTIC OPSOCLONUS MYOCLONUS; PEDIATRICS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRESCHOOL CHILD; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

ANTINEOPLASTIC AGENTS; B-LYMPHOCYTES; BLOOD CELLS; CASE-CONTROL STUDIES; CD4-CD8 RATIO; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOPHENOTYPING; INFANT; KILLER CELLS, NATURAL; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTES; MALE; NEUROBLASTOMA; PARANEOPLASTIC SYNDROMES, NERVOUS SYSTEM; T-LYMPHOCYTE SUBSETS;

EID: 9644289413     PISSN: 10774114     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043426-200411000-00006     Document Type: Article

References (20)

1. Kinsbourne M. Myoclonic encephalopathy of infancy. J Neurol Neurosurg Psychiatry. 1962;25:271-276.
2. Altman AJ, Baehner RL. Favorable prognosis for survival in children with coincident opso-myoclonus and neuroblastoma. Cancer. 1976;37:846-852.
3. Solomon GE, Chutorian AM. Opsoclonus and occult neuroblastoma. N Engl J Med. 1968;279:475-477.
4. Pranzatelli MR. The immunopharmacology of the opsoclonus-myoclonus syndrome. Clin Neuropharmacol. 1996;19:1-47.
5. Pranzatelli MR. The neurobiology of opsoclonus-myoclonus. Clin Neuropharmacol. 1992;15:186-228.
6. Rudnick E, Khakoo Y, Antunes N, et al. Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: clinical outcome and anti-neural antibodies - a Children's Cancer Group study. Med Pediatr Oncol. 2001;36:612-622.
7. Pranzatelli MR, Tate ED, Wheeler A, et al. Screening for autoantibodies in children with opsoclonus-myoclonus-ataxia. Pediatr Neurol. 2002;27:384-387.
8. Pranzatelli MR, Travelstead A, Tate ED, et al. B- and T-cell markers in opsoclonus-myoclonus syndrome: immunophenotyping of CSF lymphocytes. Neurology. 2004;62:1526-1532.
9. Pranzatelli MR, Tate ED, Galvan I, et al. A controlled pilot study of piracetam for pediatric opsoclonus-myoclonus. Clin. Neuropharmacol. 2001;24:352-357.
10. Comans-Bitter WM, De Goot R, van den Beemd R, et al. Immunophenotyping of blood lymphocytes in childhood. Reference values for lymphocyte subpopulations. J Pediatr. 1997;130:388-393.
11. Kotylo PK, Fineberg NS, Freeman KS, et al. Reference ranges for lymphocyte subsets in pediatric patients. Am J Clin Pathol. 1993;100:111-115.
12. Hulstaert F, Hannet I, Deneys V, et al. Age-related changes in human blood lymphocyte subpopulations. Clin Immunity Immunol. 1994;70:152-158.
13. SAS/STAT User's Guide. Release 8.2. Cary, NC: SAS Institute Inc, 2002.
14. Talon PH, Stoll C. Syndrome opso-myoclonique de l'enfant. Nouvelle observations. Revue de la litterature (110 cas). Pediatrie. 1985;40:441-449.
15. Sugie H, Sugie Y, Akimoto H, et al. High-dose IV human immunoglobulin in a case with infantile opsoclonus polymyoclonic syndrome. Acta Paediatr. 1992;81:371-372.
16. Eeg-Oloffson O, Prchal JF, Andermann F. Abnormalities of T-lymphocyte subsets in epileptic patients. Acta Neurol Scand. 1985;72:140-144.
17. Gupta S, Aggarwal S, Heads C. Dysregulated immune system in children with autism: beneficial effects of intravenous immune globulin on autistic characteristics. J Autism Dev Disord. 1996;26:439-452.
18. Frequin ST, Lamers KJ, Borm GF, et al. T-cell subsets in the cerebrospinal fluid and peripheral blood of multiple sclerosis patients treated with high-dose intravenous methylprednisolone. Acta Neurol Scand. 1993;88:80-86.
19. Lafaille JJ. The role of helper T cell subsets in autoimmune diseases. Cytol Growth Fact Rev. 1998;9:139-151.
20. Haas W. Gamma/delta cells. Annu Rev Immunol. 1993;11:637-685.